Brief: UK's MHRA Approves Vimkunya Vaccine For Chikungunya In People Aged 12 And Older
May 1 (Reuters) - UK's MHRA: UK'S MHRA: VIMKUNYA VACCINE APPROVED TO PREVENT DISEASE CAUSED BY CHIKUNGUNYA VIRUS IN PEOPLE 12 YEARS OF AGE AND OLDER Further company coverage: BAVA.CO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bavarian Nordic A/S
See all newsBrief: Bavarian Nordic Completes First Tranche Of Share Buy-Back Program
Bavarian Nordic gets four-year contract for mpox and smallpox vaccine from UK government
Brief: Bavarian Nordic Awarded Multi-Year Vaccine Contract By UK Government
Bavarian Nordic donates 75,000 mpox vaccine doses to global emergency stockpile
Brief: Bavarian Nordic Donates To Global Mpox Emergency Stockpile